Betta Pharmaceuticals (China) Price History
| 300558 Stock | 49.36 3.74 7.04% |
Below is the normalized historical share price chart for Betta Pharmaceuticals Co extending back to November 07, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Betta Pharmaceuticals stands at 49.36, as last reported on the 25th of November, with the highest price reaching 53.12 and the lowest price hitting 49.30 during the day.
If you're considering investing in Betta Stock, it is important to understand the factors that can impact its price. Betta Pharmaceuticals appears to be very steady, given 3 months investment horizon. Betta Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.16, which signifies that the company had a 0.16% return per unit of risk over the last 3 months. By analyzing Betta Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.71% is justified by implied risk. Please makes use of Betta Pharmaceuticals' Risk Adjusted Performance of 0.1174, downside deviation of 3.59, and Mean Deviation of 3.05 to double-check if our risk estimates are consistent with your expectations.
At present, Betta Pharmaceuticals' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 90.1 M, whereas Common Stock is forecasted to decline to about 341.2 M. . Betta Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 39.6305 | 50 Day MA 44.346 | Beta 0.759 |
Betta |
Sharpe Ratio = 0.1555
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 300558 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.59 actual daily | 40 60% of assets are more volatile |
Expected Return
| 0.71 actual daily | 14 86% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Betta Pharmaceuticals is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Betta Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 3.6645 | Enterprise Value Ebitda 43.7748 | Price Sales 7.4916 | Shares Float 229.6 M | Dividend Share 0.17 |
Betta Pharmaceuticals Stock Price History Chart
There are several ways to analyze Betta Stock price data. The simplest method is using a basic Betta candlestick price chart, which shows Betta Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 21, 2024 | 53.1 |
| Lowest Price | August 23, 2024 | 33.61 |
Betta Pharmaceuticals November 25, 2024 Stock Price Synopsis
Various analyses of Betta Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Betta Stock. It can be used to describe the percentage change in the price of Betta Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Betta Stock.| Betta Pharmaceuticals Price Action Indicator | (3.72) | |
| Betta Pharmaceuticals Price Daily Balance Of Power | (0.98) | |
| Betta Pharmaceuticals Price Rate Of Daily Change | 0.93 |
Betta Pharmaceuticals November 25, 2024 Stock Price Analysis
Betta Stock Price History Data
The price series of Betta Pharmaceuticals for the period between Tue, Aug 27, 2024 and Mon, Nov 25, 2024 has a statistical range of 19.49 with a coefficient of variation of 14.39. The prices are distributed with arithmetic mean of 42.07. The median price for the last 90 days is 43.33. The company issued dividends on 2024-06-06.| Open | High | Low | Close | Volume | ||
11/25/2024 | 52.81 | 53.12 | 49.30 | 49.36 | ||
| 11/22/2024 | 52.81 | 53.12 | 49.30 | 49.36 | 10,740,007 | |
| 11/21/2024 | 52.36 | 55.08 | 51.36 | 53.10 | 14,447,543 | |
| 11/20/2024 | 46.80 | 54.87 | 46.80 | 52.81 | 20,801,279 | |
| 11/19/2024 | 46.32 | 47.17 | 45.92 | 46.95 | 4,225,118 | |
| 11/18/2024 | 47.39 | 47.88 | 45.71 | 46.00 | 5,656,828 | |
| 11/15/2024 | 48.51 | 48.66 | 47.35 | 47.39 | 4,966,806 | |
| 11/14/2024 | 49.50 | 49.60 | 48.38 | 48.51 | 4,588,199 | |
| 11/13/2024 | 50.06 | 50.50 | 48.57 | 49.60 | 6,715,539 | |
| 11/12/2024 | 50.37 | 51.80 | 49.80 | 50.28 | 10,059,246 | |
| 11/11/2024 | 48.43 | 50.85 | 47.94 | 50.47 | 9,735,640 | |
| 11/08/2024 | 49.73 | 50.28 | 48.68 | 48.98 | 9,216,366 | |
| 11/07/2024 | 50.00 | 50.95 | 49.00 | 49.65 | 9,930,587 | |
| 11/06/2024 | 48.00 | 50.40 | 47.51 | 49.40 | 11,529,060 | |
| 11/05/2024 | 46.72 | 48.25 | 46.27 | 48.07 | 8,878,414 | |
| 11/04/2024 | 46.30 | 47.78 | 46.25 | 46.95 | 6,896,748 | |
| 11/01/2024 | 45.88 | 47.87 | 45.47 | 45.66 | 8,352,300 | |
| 10/31/2024 | 45.55 | 46.42 | 44.39 | 46.06 | 11,688,700 | |
| 10/30/2024 | 46.83 | 47.22 | 44.78 | 45.38 | 9,735,300 | |
| 10/29/2024 | 48.84 | 49.78 | 46.62 | 46.80 | 11,092,750 | |
| 10/28/2024 | 46.10 | 48.33 | 45.68 | 47.95 | 12,026,597 | |
| 10/25/2024 | 45.73 | 46.99 | 44.30 | 46.97 | 14,122,900 | |
| 10/24/2024 | 45.89 | 46.65 | 45.51 | 46.01 | 7,996,710 | |
| 10/23/2024 | 46.17 | 46.80 | 45.68 | 45.88 | 7,549,210 | |
| 10/22/2024 | 46.58 | 47.11 | 45.60 | 46.24 | 7,455,731 | |
| 10/21/2024 | 45.78 | 47.42 | 45.09 | 46.68 | 10,800,213 | |
| 10/18/2024 | 42.96 | 47.22 | 42.60 | 45.40 | 11,389,089 | |
| 10/17/2024 | 43.73 | 44.10 | 42.80 | 42.86 | 6,034,618 | |
| 10/16/2024 | 43.06 | 44.65 | 42.82 | 43.33 | 6,428,028 | |
| 10/15/2024 | 44.33 | 46.20 | 43.92 | 44.03 | 10,425,900 | |
| 10/14/2024 | 43.50 | 44.65 | 42.01 | 44.33 | 9,847,384 | |
| 10/11/2024 | 46.80 | 46.80 | 42.20 | 43.06 | 11,318,305 | |
| 10/10/2024 | 47.24 | 50.32 | 46.80 | 47.00 | 13,881,408 | |
| 10/09/2024 | 50.05 | 51.02 | 46.68 | 46.80 | 17,905,076 | |
| 10/08/2024 | 54.88 | 54.88 | 47.97 | 52.48 | 22,946,007 | |
| 09/30/2024 | 42.50 | 46.30 | 41.66 | 45.97 | 18,138,299 | |
| 09/27/2024 | 37.87 | 40.70 | 37.30 | 40.28 | 14,599,416 | |
| 09/26/2024 | 35.00 | 37.15 | 34.48 | 37.00 | 11,607,753 | |
| 09/25/2024 | 35.28 | 36.49 | 35.05 | 35.18 | 11,292,790 | |
| 09/24/2024 | 34.43 | 35.40 | 33.41 | 35.27 | 12,556,544 | |
| 09/23/2024 | 36.52 | 36.68 | 34.35 | 34.44 | 10,864,220 | |
| 09/20/2024 | 37.55 | 38.00 | 35.90 | 36.23 | 10,058,539 | |
| 09/19/2024 | 37.63 | 38.55 | 37.30 | 37.45 | 8,643,847 | |
| 09/18/2024 | 39.00 | 39.28 | 36.65 | 37.36 | 12,560,654 | |
| 09/13/2024 | 39.59 | 40.33 | 38.90 | 39.28 | 8,651,032 | |
| 09/12/2024 | 39.88 | 40.56 | 39.00 | 39.40 | 9,811,360 | |
| 09/11/2024 | 37.26 | 40.73 | 37.08 | 40.16 | 15,721,445 | |
| 09/10/2024 | 36.86 | 37.65 | 36.19 | 37.26 | 6,092,500 | |
| 09/09/2024 | 37.05 | 37.80 | 36.63 | 36.90 | 6,708,683 | |
| 09/06/2024 | 37.24 | 38.42 | 37.10 | 37.34 | 9,866,922 | |
| 09/05/2024 | 35.55 | 37.58 | 35.55 | 37.34 | 10,765,414 | |
| 09/04/2024 | 35.33 | 36.03 | 35.02 | 35.42 | 4,625,600 | |
| 09/03/2024 | 34.25 | 36.10 | 34.02 | 35.48 | 8,136,449 | |
| 09/02/2024 | 35.43 | 35.62 | 34.25 | 34.28 | 7,129,014 | |
| 08/30/2024 | 35.03 | 36.32 | 34.75 | 35.50 | 8,352,714 | |
| 08/29/2024 | 34.15 | 35.25 | 34.09 | 35.03 | 5,602,934 | |
| 08/28/2024 | 34.36 | 35.08 | 34.22 | 34.30 | 4,442,953 | |
| 08/27/2024 | 34.05 | 35.18 | 34.01 | 34.62 | 5,156,136 | |
| 08/26/2024 | 33.33 | 34.20 | 33.00 | 34.15 | 5,611,636 | |
| 08/23/2024 | 35.15 | 35.24 | 33.43 | 33.61 | 8,058,600 | |
| 08/22/2024 | 35.83 | 36.16 | 34.79 | 35.10 | 5,188,711 |
About Betta Pharmaceuticals Stock history
Betta Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Betta is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Betta Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Betta Pharmaceuticals stock prices may prove useful in developing a viable investing in Betta Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 418.5 M | 450.6 M | |
| Net Income Applicable To Common Shares | 440.5 M | 370.7 M |
Betta Pharmaceuticals Stock Technical Analysis
Betta Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
| All Next | Launch Module |
Betta Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Betta Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Betta Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Betta to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1174 | |||
| Jensen Alpha | 0.6101 | |||
| Total Risk Alpha | (0.08) | |||
| Sortino Ratio | 0.1379 | |||
| Treynor Ratio | 13.8 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Betta Stock analysis
When running Betta Pharmaceuticals' price analysis, check to measure Betta Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Betta Pharmaceuticals is operating at the current time. Most of Betta Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Betta Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Betta Pharmaceuticals' price. Additionally, you may evaluate how the addition of Betta Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |